Mentalyc vs Upheal
These are the two most buyable products in behavioral health documentation for solo clinicians and small practices, and the only two in this index's behavioral health lane publishing both full pricing and a SOC 2 Type II attestation, with HIPAA and Canadian PHIPA coverage besides. The split is scope and stewardship. Mentalyc is a documentation specialist with the strongest privacy posture in the lane: it states plainly that it does not train on clinician or client data and does not retain session recordings, and recording is optional rather than required. Upheal is an AI native EHR: notes plus scheduling, billing, telehealth, client portal, and compliance checking in one platform at $1 per session capped at $69 a month, with Golden Thread maintaining the diagnosis to treatment plan to progress note continuity that payers audit for medical necessity. If your failure mode is where session data goes, start with Mentalyc. If your failure mode is running a practice across too many tools, start with Upheal.
- Data stewardship decides it: the company states it does not train on clinician or client data and does not retain session recordings, the specific disclosure this index has not found from any other behavioral health vendor.
- You will not record therapy, or your clients will not: notes generate from uploaded audio, dictation, transcripts, or typed summaries as well as recordings, so capture is an option rather than a requirement.
- Therapy native formats and low entry cost: SOAP, DAP, BIRP, PIRP, GIRP, PIE, and SIRP plus a reported 100 or more custom templates, with published tiers from a Mini plan near $19.99 a month.
- You want the practice stack, not another tool: AI notes, scheduling, billing, treatment plans, a client portal, forms, payments, and HIPAA secure telehealth in one platform.
- The pricing model matches a variable caseload: $1 per session capped at $69 a month per provider with no seat fees and no AI add on, so a lighter month costs less.
- Audit continuity is your exposure: Golden Thread links diagnosis, treatment plan goals, and session progress notes automatically, and the compliance checker flags documentation gaps before submission.
Side-by-Side
| Axis | M Mentalyc |
U Upheal |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Both vendors' feature and adoption claims are vendor published. Both carry a clinical evidence grade of C: neither has a peer reviewed outcome study on record with this index. Mentalyc publishes extensive comparison content evaluating its own competitors, including vendors indexed here; this comparison relies on the index's independent capability records rather than either vendor's competitive materials. Upheal restructured its tiers into the usage based model in 2026, so older third party descriptions of Free, Starter, and Premium plans no longer reflect current pricing.